Mr. Anthony Schaller reports

LIGHT AI WELLNESS APPLICATION Q3 2025 LAUNCH

Light AI Inc. has achieved key internal milestones in the development of its Wellness Strep A screening application.

"We have made significant progress in the development of the company's commercial platform since the beginning of 2025. These include the introduction of a multiplatform version of our mobile application with both Android and IOS smart phone and tablet support as well as robust scalability and security for our hyper-scale-based back-end AI systems," stated Anthony Schaller, president and chief technology officer of Light AI. "This significant product development investment positions the company well as it transitions to its commercialization phase."

The company's artificial-intelligence-powered software platform is currently undergoing internal user testing by Light AI and its low and middle income countries go-to-market partner, Tech Care For All.

The company continues to progress with its initial commercialization efforts for its wellness application, inclusive of potential targeted market-demonstration deployments with pharmacy companies. Commercial availability of the company's wellness application remains targeted for late 2025.

The global AI health care market is projected to reach $110.6-billion (U.S.) by 2030 from $21.7-billion (U.S.) in 2025, at a CAGR (compound annual growth rate) of approximately 39 per cent based upon adoption to new AI health and wellness solutions. The market is anticipated to grow due to the growing investments and funding by public-private organizations, the fast proliferation of AI in the healthcare industry, and the rising focus on developing human-aware AI systems. The market is experiencing growth due to increasing demand for enhanced services due to an unequal ratio between the healthcare work force and patient numbers. However, inadequate IT infrastructure and unwillingness to adopt AI-based health care solutions in emerging economies are estimated to pose a challenge to market growth to be addressed.

"We are receiving positive feedback to Light AI's wellness application anticipated to support our initial commercialization initiatives," stated John Tse, vice-president of commercial development. "We look forward to making a positive impact in the health and wellness market's digital health paradigm shift evolution."

About Light AI Inc.

Light AI is a technology company focused on developing artificial intelligence health screening and diagnostic solutions. Light AI is developing a technology platform which represents the next generation of patient management: it applies AI algorithms to smart phone images -- starting with images of Strep A and anticipated expansion with COVID-19 along with other medical conditions -- to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind -- its hardware platform is the 4.5 billion smart phones that exist in the world today. Light AI is at the forefront of developing innovative screening and diagnostic solutions aimed at improving health care delivery worldwide. Their cutting-edge AI powered technology offers rapid, accurate, and cost-effective screening and diagnostic tools designed to address critical healthcare challenges.

In pre-FDA (Food and Drug Administration) validation studies, Light AI's algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS). The algorithm achieved a 96.57-per-cent accuracy rate and attained a negative predictive value of 100 per cent, indicating its high reliability in confirming the absence of Streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as Rheumatic Heart Disease (RHD), which imposes a global economic burden exceeding $1-trillion annually. Light AI's technology offers a significant advancement in the accurate and timely identification of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI's approach to applying AI to smart phone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin. Light AI's vision is to combine the smart phone with AI in the cloud to create a digital clinical lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes. Light AI's commercial launch of its consumer-facing wellness app initial offering is anticipated to be available in North America in Q3 2025.

We seek Safe Harbor.